TrialBJU international2021
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
Ravi A Madan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it